The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hodgkin Disease

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hodgkin Disease


Psychiatry related information on Hodgkin Disease


High impact information on Hodgkin Disease


Chemical compound and disease context of Hodgkin Disease


Biological context of Hodgkin Disease


Anatomical context of Hodgkin Disease


Gene context of Hodgkin Disease


Analytical, diagnostic and therapeutic context of Hodgkin Disease


  1. Case report: development of Hodgkin's disease in patient receiving long-term administration of dacarbazine and interleukin-2 for metastatic melanoma. Flaherty, L.E., Schwert, R., Redman, B.G. J. Natl. Cancer Inst. (1990) [Pubmed]
  2. L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH. Newcom, S.R., Kadin, M.E., Ansari, A.A., Diehl, V. J. Clin. Invest. (1988) [Pubmed]
  3. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. Travis, L.B., Gospodarowicz, M., Curtis, R.E., Clarke, E.A., Andersson, M., Glimelius, B., Joensuu, T., Lynch, C.F., van Leeuwen, F.E., Holowaty, E., Storm, H., Glimelius, I., Pukkala, E., Stovall, M., Fraumeni, J.F., Boice, J.D., Gilbert, E. J. Natl. Cancer Inst. (2002) [Pubmed]
  4. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Boogaerts, M.A., Ferrant, A., Demuynck, H.M., Link, H., Zander, A., Barge, A. Lancet (1996) [Pubmed]
  5. Pulmonary toxicity of ABVD chemotherapy and G-CSF in Hodgkin's disease: possible synergy. Matthews, J.H. Lancet (1993) [Pubmed]
  6. Thyroid cancer following radiotherapy for Hodgkin's disease: a case report and review of the literature. Moroff, S.V., Fuks, J.Z. Med. Pediatr. Oncol. (1986) [Pubmed]
  7. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. Hummel, M., Ziemann, K., Lammert, H., Pileri, S., Sabattini, E., Stein, H. N. Engl. J. Med. (1995) [Pubmed]
  8. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. Canellos, G.P., Anderson, J.R., Propert, K.J., Nissen, N., Cooper, M.R., Henderson, E.S., Green, M.R., Gottlieb, A., Peterson, B.A. N. Engl. J. Med. (1992) [Pubmed]
  9. Plasma-cell dyscrasia after alkylating-agent therapy for Hodgkin's disease. Gelmann, E.P., Dennis, L.H. N. Engl. J. Med. (1981) [Pubmed]
  10. Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease. Kadin, M.E., Stites, D.P., Levy, R., Warnke, R. N. Engl. J. Med. (1978) [Pubmed]
  11. Prostaglandin-producing suppressor cells in Hodgkin's disease. Goodwin, J.S., Messner, R.P., Bankhurst, A.D., Peake, G.T., Saiki, J.H., Williams, R.C. N. Engl. J. Med. (1977) [Pubmed]
  12. Use of levamisole in Hodgkin's disease. Berényi, E., Sonkoly, I., Kávai, M., Szabolcsi, M., Szegedi, G. N. Engl. J. Med. (1977) [Pubmed]
  13. A new combination chemotherapy for resistant Hodgkin disease. Vinciguerra, V., Coleman, M., Jarowski, C.I., Degnan, T.J., Silver, R.T. JAMA (1977) [Pubmed]
  14. Combination chemotherapy with doxorubicin and lomustine. Treatment of refractory Hodgkin's disease. Williams, S.D., Einhorn, L.H. JAMA (1977) [Pubmed]
  15. Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease. Siber, G.R., Gorham, C., Martin, P., Corkery, J.C., Schiffman, G. Ann. Intern. Med. (1986) [Pubmed]
  16. Virus-cell interactions in a natural killer-like cell line from a patient with lymphoblastic lymphoma. Kanegane, H., Wang, F., Tosato, G. Blood (1996) [Pubmed]
  17. Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Marafioti, T., Pozzobon, M., Hansmann, M.L., Delsol, G., Pileri, S.A., Mason, D.Y. Blood (2004) [Pubmed]
  18. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Stein, H., Marafioti, T., Foss, H.D., Laumen, H., Hummel, M., Anagnostopoulos, I., Wirth, T., Demel, G., Falini, B. Blood (2001) [Pubmed]
  19. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor. Gruss, H.J., Ulrich, D., Dower, S.K., Herrmann, F., Brach, M.A. Blood (1996) [Pubmed]
  20. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Schmitz, N., Pfistner, B., Sextro, M., Sieber, M., Carella, A.M., Haenel, M., Boissevain, F., Zschaber, R., Müller, P., Kirchner, H., Lohri, A., Decker, S., Koch, B., Hasenclever, D., Goldstone, A.H., Diehl, V. Lancet (2002) [Pubmed]
  21. Restin: a novel intermediate filament-associated protein highly expressed in the Reed-Sternberg cells of Hodgkin's disease. Bilbe, G., Delabie, J., Brüggen, J., Richener, H., Asselbergs, F.A., Cerletti, N., Sorg, C., Odink, K., Tarcsay, L., Wiesendanger, W. EMBO J. (1992) [Pubmed]
  22. T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. Renner, C., Ohnesorge, S., Held, G., Bauer, S., Jung, W., Pfitzenmeier, J.P., Pfreundschuh, M. Blood (1996) [Pubmed]
  23. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Emmerich, F., Meiser, M., Hummel, M., Demel, G., Foss, H.D., Jundt, F., Mathas, S., Krappmann, D., Scheidereit, C., Stein, H., Dörken, B. Blood (1999) [Pubmed]
  24. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Osaka, M., Rowley, J.D., Zeleznik-Le, N.J. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  25. Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor. Annunziata, C.M., Safiran, Y.J., Irving, S.G., Kasid, U.N., Cossman, J. Blood (2000) [Pubmed]
  26. Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Fiumara, P., Snell, V., Li, Y., Mukhopadhyay, A., Younes, M., Gillenwater, A.M., Cabanillas, F., Aggarwal, B.B., Younes, A. Blood (2001) [Pubmed]
  27. Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease. Takagi, M., Tsuchida, R., Oguchi, K., Shigeta, T., Nakada, S., Shimizu, K., Ohki, M., Delia, D., Chessa, L., Taya, Y., Nakanishi, M., Tsunematsu, Y., Bessho, F., Isoyama, K., Hayashi, Y., Kudo, K., Okamura, J., Mizutani, S. Blood (2004) [Pubmed]
  28. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines. Delabie, J., Ceuppens, J.L., Vandenberghe, P., de Boer, M., Coorevits, L., De Wolf-Peeters, C. Blood (1993) [Pubmed]
  29. Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease. Molrine, D.C., George, S., Tarbell, N., Mauch, P., Diller, L., Neuberg, D., Shamberger, R.C., Anderson, E.L., Phillips, N.R., Kinsella, K., Ambrosino, D.M. Ann. Intern. Med. (1995) [Pubmed]
  30. Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Olsson, L., Kaplan, H.S. Proc. Natl. Acad. Sci. U.S.A. (1980) [Pubmed]
  31. Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections. Brousset, P., Chittal, S., Schlaifer, D., Icart, J., Payen, C., Rigal-Huguet, F., Voigt, J.J., Delsol, G. Blood (1991) [Pubmed]
  32. High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease. Kessinger, A., Bierman, P.J., Vose, J.M., Armitage, J.O. Blood (1991) [Pubmed]
WikiGenes - Universities